Perkins v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedFebruary 2, 2021
Docket17-487
StatusPublished

This text of Perkins v. Secretary of Health and Human Services (Perkins v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Perkins v. Secretary of Health and Human Services, (uscfc 2021).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-487V Filed: January 8, 2021

* * * * * * * * * * * * * * * BARBARA PERKINS, * To Be Published * Petitioner, * v. * Finding of Facts; Onset; Tetanus- * diphtheria-acellular pertussis (“Tdap”) SECRETARY OF HEALTH * Vaccine; Guillain-Barre Syndrome AND HUMAN SERVICES, * (“GBS”); Miller-Fisher Variant (“MFV”) * Respondent. * * * * * * * * * * * * * * * * * *

Lawrence Michel, Esq., Kennedy Berkley, et al., Salina, KS, for petitioner. Mallori Openchowski, Esq., U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ONSET1 Roth, Special Master: On April 6, 2017, Barbara Perkins (“petitioner”) filed a petition pursuant to the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 et seq.2 (“Vaccine Act” or “the Program”). Petitioner alleged that as a result of a tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine she received on November 2, 2015 she developed the Miller-Fisher variant (“MFV”) of Guillain-Barré syndrome (“GBS”). Petition at 1, ECF No. 1. As explained below, I find that petitioner’s symptoms of dizziness, double vision, and ataxia, associated with her diagnosis of Miller-Fisher variant GBS, began after January 4, 2016.

1 This Ruling has been designated “to be published,” which means I am directing it to be posted on the Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Ruling will be available to anyone with access to the internet. However, the parties may object to the Ruling’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Ruling will be available to the public. Id. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). I. Procedural History

The petition was filed on April 6, 2017, along with an affidavit from petitioner as an attachment. ECF No. 1. On April 7, 2017, petitioner’s affidavit was again filed; neither filing of the affidavit was designated as an exhibit. ECF No. 4. Petitioner filed medical records on May 8, 2017. Petitioner’s Exhibits (“Pet. Ex.”) 1-7, ECF No. 8.

The initial status conference was held on May 17, 2017. Respondent was ordered to file a status report identifying any missing medical records and provide his position by July 17, 2017. Scheduling Order at 1, ECF No. 9. That same day, petitioner’s affidavit was refiled designated as “Pet. Ex. 8.” ECF No. 10.

After requesting and receiving multiple extensions of time, respondent filed a status report on October 19, 2017, requesting a deadline for his Rule 4(c) Report. See Respondent’s Status Report (“Resp. S.R.”), ECF No. 12; Non-PDF Order, issued July 17, 2017; Resp. S.R., ECF No. 13; Non-PDF Order, issued Sept. 15, 2017; Resp. S.R., ECF No. 14.

Respondent filed his Rule 4(c) Report (“Resp. Rpt.”) on December 4, 2017, recommending against compensation. ECF No. 15. Respondent postured that “petitioner has not offered any evidence to show that the onset of her alleged vaccine injury (at least eight weeks after vaccination) occurred in a time frame within which vaccine causation could be ascribed.” Resp. Rpt. at 8. Respondent pointed out that when petitioner presented for a mammogram on November 9, 2015, she “completed a fall risk questionnaire, in which she noted that she had no difficulty with walking or balance.” Id. at 2 n.2 (citing Pet. Ex. 2 at 274). Further, petitioner identified the onset of her symptoms as January 1, 2016 and January 2, 2016 when seeking treatment. Id. at 4 n.3 (citing Pet. Ex. 1A at 32); id. at 4 n.4 (citing Pet. Ex. 2 at 86). Respondent pointed out that onset contained in the medical records conflicted with petitioner’s affidavit, in which she affirmed that her symptoms began in mid-December 2015. Id. at 5. Respondent also noted concerns regarding the six-month requirement and alternative causes of petitioner’s condition. Id. at 4 n.4, 5, 6, 8.

Petitioner filed additional medical records on January 17, 2018. Pet. Ex. 9-11, ECF No. 21. A status conference was held on January 18, 2018, during which the issues raised in the Rule 4(c) Report were discussed. Scheduling Order at 1, ECF No. 23. Petitioner’s counsel requested the opportunity to consult with an expert, and if appropriate, file an expert report addressing the onset issue, six-month requirement, and suggestion of alternate causes. Id. at 1-2.

Petitioner filed an expert report and CV from Dr. David Axelrod, an immunologist, on February 9, 2018. Pet. Ex. 12-13, ECF No. 24. In Dr. Axelrod’s initial report, he placed the onset of petitioner’s symptoms one week prior to January 6, 2016 consistent with the contemporaneous medical records filed in this matter. Pet. Ex. 12 at 1640. He then later concluded that the onset was in mid-December, approximately 42 days after her receipt of the Tdap vaccine based on petitioner’s affidavit. Id.

Following several extensions of time, on July 2, 2018, respondent filed an expert report from Dr. Timothy Vartanian, a neurologist. See Motion for Extension of Time (“MFET”), ECF No. 26; Non-PDF Order, issued Apr. 9, 2018; MFET, ECF No. 27; Non-PDF Order, issued May

2 24, 2018; MFET, ECF No. 28; Non-PDF Order, issued June 22, 2018; Resp. Ex. A, ECF No. 29. Dr. Vartanian opined that petitioner’s clinical picture fit with an onset in early January. Resp. Ex. A at 12-13.

Petitioner filed a supplemental expert report from Dr. Axelrod on July 12, 2018. Pet. Ex. 19, ECF No. 31. Dr. Axelrod wrote that petitioner reported an onset of loss of balance, double vision, weakness, and difficulty with speech on December 15, 2015. Id. at 1790. However, this information is contained in petitioner’s affidavit with no support found in any of the contemporaneous medical records and no citation by Dr. Axelrod to any medical record.

Respondent filed medical literature on October 1, 2018, and a responsive expert report from Dr. Vartanian on October 10, 2018. Resp. Ex. A, Tabs 1-9, ECF No. 34; Resp. Ex. A, Tabs 10-12, ECF No. 35; Resp. Ex. C, ECF No. 36.

A Rule 5 status conference was held on December 19, 2018. Scheduling Order, ECF No. 37. During the conference, the discrepancies in onset presented in petitioner’s affidavit and Dr. Axelrod’s reports, in contrast with the contemporaneous medical records were discussed. Id. at 3- 4. Petitioner’s counsel admitted that Dr. Axelrod’s opinion was predicated on an onset in mid- December and requested time to confer with Dr. Axelrod about whether Dr. Axelrod could support an onset of symptoms beginning in January. Id.

Petitioner filed a status report on February 4, 2019 advising that Dr. Axelrod could only support a theory of causation if petitioner’s symptoms began in mid-December 2015. ECF No. 38 at 1. Petitioner requested “the opportunity to provide live testimony to the Court addressing the inconsistency between her affidavit and medical records regarding the onset of symptoms.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Perkins v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/perkins-v-secretary-of-health-and-human-services-uscfc-2021.